Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest investors, raised $301.5 million in an upsized US initial public ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the most profitable biotech stocks to buy now. On April 13, ...

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...

If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...

What recent price moves tell you about Hangzhou Diagens Biotechnology Hangzhou Diagens Biotechnology (SEHK:2526) has drawn attention after a 6.3% move over the past day, adding to gains of about 23.1% ...

State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company, is seeking to raise as much as $212 million in a US ...

Massachusetts’ biotech sector has been shedding jobs at a painful clip — but while some companies are cutting deep, one has spent more than $20 billion acquiring five of the state’s most promising ...

Join us for a landmark discussion celebrating the remarkable journey of the biotechnology industry, from its foundational moments to the groundbreaking innovations of today. As we mark the 50th ...

Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...